Oral checks warding off jaw osteonecrosis
A once-feared adverse effect of antiresorptive treatments, osteonecrosis of the jaw, has been almost banished from Australia following the introduction of routine dental checks, endocrinologists say.
The condition used to be seen in as many as one in five cancer patients receiving high doses of antiresorptive drugs to prevent bone disease.
However, now the complication is rarely seen, a study by specialists at the Peter MacCallum Cancer Centre in Melbourne shows.
The introduction of guidelines in 2008 advising oral health assessments for all patients using